Provided by Tiger Trade Technology Pte. Ltd.

GlucoTrack, Inc.

2.31
+0.04001.76%
Volume:20.90K
Turnover:47.04K
Market Cap:1.84M
PE:-0.02
High:2.31
Open:2.25
Low:2.20
Close:2.27
52wk High:136.29
52wk Low:2.20
Shares:798.40K
Float Shares:759.70K
Volume Ratio:0.42
T/O Rate:2.75%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-112.7747
EPS(LYR):-468.2383
ROE:-620.63%
ROA:-164.45%
PB:-1.06
PE(LYR):0.00

Loading ...

GlucoTrack Amends Private Placement Warrants, Ties Exercise to Shareholder Approval Under NASDAQ Rules

Reuters
·
Yesterday

NASDAQ Trade Halt Volatility Trading Pause at 09:49 Am

Reuters
·
Sep 11

GlucoTrack Announces USD 11.5 Million Convertible Notes Offering

Reuters
·
Sep 11

GlucoTrack Announces $11.5 Million Financing

THOMSON REUTERS
·
Sep 11

GlucoTrack Issues $2 Million 5% Convertible Note to Alto Opportunity Master Fund in Settlement Deal

Reuters
·
Sep 10

GlucoTrack Unit Lōkahi Therapeutics Expands Ai² Platform into Three Divisions

Reuters
·
Sep 08

GlucoTrack announces collaboration with SDSU Fowler College of Business

TIPRANKS
·
Sep 02

LŌKahi Therapeutics™ Expands AI² Futures Lab™ Asset Origination Network Through Collaboration with San Diego State University Fowler College of Business

THOMSON REUTERS
·
Sep 02

GlucoTrack Inc trading halted, news pending

TIPRANKS
·
Aug 29

NASDAQ Trade Halt Halt News Pending at 07:50 Pm

Reuters
·
Aug 29

GlucoTrack Amends 8-K to Add Accountant Review Report for Lokahi Interim Financials

Reuters
·
Aug 29

GlucoTrack to Enact 1-for-15 Reverse Stock Split Aug. 31

Reuters
·
Aug 27

GlucoTrack, Inc. Announces Reverse Stock Split

THOMSON REUTERS
·
Aug 27

GlucoTrack subsidiary initiates clinical trial manufacturing for LT-100

TIPRANKS
·
Aug 25

GlucoTrack Unit Lokahi Therapeutics Starts GMP Manufacturing for LT-100 Osteoarthritis Pain Candidate

Reuters
·
Aug 25

LŌKahi Therapeutics™ Initiates Clinical Trial Manufacturing for Lt-100

THOMSON REUTERS
·
Aug 25

GlucoTrack Unit Lokahi Therapeutics Expands Ai2 Futures Lab Collaboration with University of Georgia

Reuters
·
Aug 21

LŌKahi Therapeutics™ Expands AI² Futures Lab™ Asset Origination Network Through Continued Collaboration with the University of Georgia

THOMSON REUTERS
·
Aug 21

GlucoTrack Holds Annual Shareholder Meeting with 36.1% of Shares Represented

Reuters
·
Aug 19

Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation

Reuters
·
Aug 17